Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Pulmonary Pharmacology & Therapeutics|October 15, 2022
Comparative clinical pharmacology of mometasone furoate, fluticasone propionate and fluticasone furoatePeter T Daley-Yates, Amanda Deans, Rashmi Mehta, et al.
Pulmonary Pharmacology & Therapeutics|September 8, 2012
28-Day safety and tolerability of umeclidinium in combination with vilanterol in COPD: a randomized placebo-controlled trialGregory Feldman, Robert R Walker, Jean Brooks, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 8, 2015
Effect of severe renal impairment on umeclidinium and umeclidinium/vilanterol pharmacokinetics and safety: a single-blind, nonrandomized studyRashmi Mehta, Kelly Hardes, Noushin Brealey, et al.
Respiratory Medicine|March 22, 2005
Comparison of the systemic pharmacodynamic effects and pharmacokinetics of salmeterol delivered by CFC propellant and non-CFC propellant metered dose inhalers in healthy subjectsRodger Kempsford, Malcolm Handel, Rashmi Mehta, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 13, 2025
Analysis of C4 Concentrations to Predict Impact of Patient-Reported Diarrhea Associated With the Ileal Bile Acid Transporter Inhibitor LinerixibatFernando Carreño, Rashmi Mehta, Andrea Ribeiro de Souza, et al.
Clinical Pharmacokinetics|April 24, 2014
Population pharmacokinetics of inhaled umeclidinium and vilanterol in patients with chronic obstructive pulmonary diseaseNavin Goyal, Misba Beerahee, Chris Kalberg, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|January 30, 2016
Systemic Exposures of Fluticasone Propionate and Salmeterol Following Inhalation via Metered Dose Inhaler with the Mini Spacer Compared with the Aerochamber Plus SpacerRashmi Mehta, Mickael Montembault, Francis Warren, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 1, 2015
Pharmacokinetics of fluticasone furoate, umeclidinium, and vilanterol as a triple therapy in healthy volunteersNoushin Brealey, Ashutosh Gupta, Jessica Renaux, et al.
Clinical Pharmacology and Therapeutics|November 13, 2023
Population Dose-Response-Time Analysis of Itch Reduction and Patient-Reported Tolerability Supports Phase III Dose Selection for LinerixibatFernando Carreño, Eleni Karatza, Rashmi Mehta, et al.
Clinical Drug Investigation|March 26, 2015
Comparison of the Pharmacokinetics of Salmeterol and Fluticasone Propionate 50/100 µg Delivered in Combination as a Dry Powder Via a Capsule-Based Inhaler and a Multi-Dose InhalerRashmi Mehta, Kylie Riddell, Ashutosh Gupta, et al.
Pageof 6